In recent years, the Ahn lab has focused on the following areas: the detection of low-frequency mutations on a genome-wide level using a novel deep sequencing technology termed Duplex Sequencing (DS); and the regulation of cell function by microenvironments such as extracellular matrix (ECM)-biomimetic nanotopography. We have applied these cutting-edge experimental approaches to study genomic changes and migratory phenotypes of breast cancer and glioblastoma. The ultimate goals of the Ahn lab’s current and future research projects are to identify biomarkers for the early detection of therapy resistance and tumor recurrence using cutting-edge deep sequencing and ECM-biomimetics technologies, and to develop a novel strategy for preclinical screening of anti-migratory chemotherapeutic agents.
For more information on ‘ongoing projects’ and ‘recently completed projects’, please visit the Ahn lab web page.
- Instructor, Biomedical Engineering
- Post-doctoral researcher, Pathology and Laboratory Medicine, University of Pennsylvania
- Post-doctoral researcher, Human Nutrition, Columbia University
- PhD, Biochemical Nutrition, Environmental Toxicology, Michigan State University
- MS, Biochemical Nutrition, Michigan State University
- BS, Chemistry, Home Economics Education, Chung-Ang University, Seoul, South Korea